Pac Premier
Giving Guide
You are here:  Home  >  Top Stories  >  Top Story  >  Current Article

MannKind shifts to marketing inhaler technology

By   /   Friday, September 7th, 2018  /   Comments Off on MannKind shifts to marketing inhaler technology

    Print       Email
Biopharmaceutical MannKind, which has its headquarters in Westlake Village, is positioning itself as a med-tech platform. (Courtesy photo) MannKind has once again disappointed its short-sellers after news of a $105 million licensing deal with Maryland-based United Therapeutics sent shares soaring more than 140 percent. MannKind announced the deal just weeks from tripping over a $20…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email